ClearPoint Neuro
CLPT
59 hedge funds and large institutions have $38.9M invested in ClearPoint Neuro in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 12 closing their positions.
236% more call options, than puts
Call options by funds: $1.19M | Put options by funds: $354K
118% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 11
8% more capital invested
Capital invested by funds: $36M → $38.9M (+$2.91M)
1.44% more ownership
Funds ownership: 17.24% → 18.68% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 62 → 59 (-3)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.04M |
| 2 |
Jane Street
New York
|
+$701K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$635K |
| 4 |
Goldman Sachs
New York
|
+$525K |
| 5 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$480K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$447K |
| 2 |
Renaissance Technologies
New York
|
-$418K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$153K |
| 4 |
PCM
Parsons Capital Management
Providence,
Rhode Island
|
-$147K |
| 5 |
Man Group
London,
United Kingdom
|
-$132K |
CLPT Hedge Fund Activity: Q1 2023 in Review
59 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2023, worth a combined $38.9M — up 8.1% from $36M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CLPT and 10 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 24 added.
The largest buyer was Millennium Management, adding an estimated $1.04M. The largest seller was Citadel Advisors, cutting an estimated $447K.
- 59 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2023, down from 62 in Q4 2022.
- Funds reported $38.9M of ClearPoint Neuro stock for Q1 2023, up 8.1% quarter-over-quarter.
- 10 funds opened new ClearPoint Neuro positions in Q1 2023 and 12 closed out, a net change of -2 holders.
- The largest ClearPoint Neuro buyer in Q1 2023 was Millennium Management, an estimated $1.04M added.
- The largest ClearPoint Neuro seller in Q1 2023 was Citadel Advisors, an estimated $447K sold.
Based on aggregated 13F filings for Q1 2023.